Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

266
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
266
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Tissue Transplantation01:24

Tissue Transplantation

314
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
314
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Stem Cell Culture01:17

Stem Cell Culture

5.0K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.0K
Embryonic Stem Cells00:57

Embryonic Stem Cells

3.3K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Long-Term Survival of Hypoimmune Allogeneic Islets without Immunosuppression.

The New England journal of medicine·2026
Same author

Transplantation tolerance versus immune evasion: Mechanistic divergences and therapeutic frontiers for islet cell replacement.

Cell reports. Medicine·2026
Same author

Allogeneic Beta Cells with No Immunosuppression. Reply.

The New England journal of medicine·2025
Same author

Hypoimmune CD19 CAR T cells evade allorejection in patients with cancer and autoimmune disease.

Cell stem cell·2025
Same author

Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression.

The New England journal of medicine·2025
Same author

Hypoimmune FK binding protein 12-knockout CD19 CAR T cells achieve deep tissue B-cell depletion and control Nalm6 tumors in immunosuppressed humanized mice.

Cytotherapy·2025

相关实验视频

Updated: May 17, 2025

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

376

在开发全源细胞疗法方面取得的进展和挑战.

Tobias Deuse1, Sonja Schrepfer2

  • 1Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology (TSI)-Lab, University of California, San Francisco, San Francisco, CA, USA.

Cell stem cell
|April 4, 2025
PubMed
概括

全基因细胞疗法通过基因工程克服免疫排斥,提供可扩展的治疗方法. 本综述探讨了创建免疫逃避细胞的策略,以获得更广泛的患者访问.

科学领域:

  • 免疫学 免疫学 免疫学
  • 细胞疗法细胞疗法
  • 基因工程是基因工程.

背景情况:

  • 目前,自主细胞疗法用于预防免疫排斥.
  • 如果克服免疫排斥,来自供体细胞的全基细胞疗法可以显著扩大患者的治疗机会.
  • 目前使用全原细胞的细胞替代疗法是有限的.

研究的目的:

  • 审查基因工程策略,以创造免疫逃避细胞.
  • 总结一下全源免疫细胞疗法的当前状况.
  • 收集关于全源细胞替代疗法的数据.

主要方法:

  • 对免疫逃避基因工程概念的文献综述.
  • 对当前所有原细胞疗法方法的分析.
  • 汇编关于全源细胞替代疗法的数据.

主要成果:

  • 基因工程提供了有希望的策略,以克服免疫排斥在全基细胞疗法.
  • 该领域的进展正在迅速推进.
  • 关于全源细胞替代疗法的数据虽然有限,但显示出潜在的潜力.

结论:

更多相关视频

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

416
Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.5K

相关实验视频

Last Updated: May 17, 2025

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

376
A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

416
Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.5K
  • 克服免疫排斥是释放全源细胞疗法的潜力的关键.
  • 基因工程是开发免疫规避性全基因细胞产品的关键工具.
  • 对全基细胞疗法的未来前景是乐观的,有希望更广泛的患者可访问性.